Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

128 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The ocular microbiome and microbiota and their effects on ocular surface pathophysiology and disorders.
Aragona P, Baudouin C, Benitez Del Castillo JM, Messmer E, Barabino S, Merayo-Lloves J, Brignole-Baudouin F, Inferrera L, Rolando M, Mencucci R, Rescigno M, Bonini S, Labetoulle M. Aragona P, et al. Among authors: mencucci r. Surv Ophthalmol. 2021 Nov-Dec;66(6):907-925. doi: 10.1016/j.survophthal.2021.03.010. Epub 2021 Apr 2. Surv Ophthalmol. 2021. PMID: 33819460 Free article. Review.
Systemic exposure to intracameral vs topical mydriatic agents: in cataract surgery.
Guell J, Behndig A, Pleyer U, Jaulerry S, Rozot P, Pisella PJ, Robert PY, Lanzl I, Pourjavan S, Aguiar C, Fernandez J, Grabner G, Mencucci R, Chiambaretta F, Labetoulle M. Guell J, et al. Among authors: mencucci r. Clin Ophthalmol. 2019 May 3;13:811-819. doi: 10.2147/OPTH.S189671. eCollection 2019. Clin Ophthalmol. 2019. PMID: 31118559 Free PMC article.
Safety and efficacy of a standardized intracameral combination of mydriatics and anesthetic for cataract surgery in type-2 diabetic patients.
Labetoulle M, Behndig A, Tassignon MJ, Nuijts R, Mencucci R, Güell JL, Pleyer U, Szaflik J, Rosen P, Bérard A, Chiambaretta F, Cochener-Lamard B; Intracameral Mydrane (ICMA), Ethics Group. Labetoulle M, et al. Among authors: mencucci r. BMC Ophthalmol. 2020 Mar 3;20(1):81. doi: 10.1186/s12886-020-01343-x. BMC Ophthalmol. 2020. PMID: 32126990 Free PMC article. Clinical Trial.
The Management of Dry Eye Disease: Proceedings of Italian Dry Eye Consensus Group Using the Delphi Method.
Aragona P, Giannaccare G, Mencucci R, Rubino P, Cantera E, Finocchiaro CY, Vaccaro S, Aiello F, Antoniazzi E, Barabino S, Bonini S, Carlini G, Chierego C, Gisoldi RAMC, Di Zazzo A, Fasciani R, Franch A, Gabbriellini G, Gagliano C, Leonardi A, Macrì A, Mosca L, Orfeo V, Pinna A, Pocobelli A, Protti R, Rama P, Rania L, Rechichi M, Russo A, Scorcia V, Spadea L, Trentadue M, Troisi S, Versura P, Villani E, Rolando M. Aragona P, et al. Among authors: mencucci r. J Clin Med. 2022 Oct 30;11(21):6437. doi: 10.3390/jcm11216437. J Clin Med. 2022. PMID: 36362665 Free PMC article.
Effectiveness of a New Active Tear Substitute Containing 0.2% Hyaluronic Acid and 0.001% Hydrocortisone on Signs and Symptoms of Dry Eye Disease by Means of Low- and High-Tech Assessments.
Fogagnolo P, Giannaccare G, Mencucci R, Villani E, Orfeo V, Aragona P; Italian Dry Eye Study Group. Fogagnolo P, et al. Among authors: mencucci r. Ophthalmol Ther. 2024 Jan;13(1):251-266. doi: 10.1007/s40123-023-00833-7. Epub 2023 Nov 10. Ophthalmol Ther. 2024. PMID: 37948015 Free PMC article.
128 results